Advances of Autoimmune Rheumatic Diseases Related to Malignant Tumors

Overview

Journal Inflamm Res

Specialties Allergy & Immunology
Pathology

Date 2023 Sep 28

PMID 37768354

Authors

Miaomiao Zhao

Liangyu Mi

Yuli Ji

Xiaoyao He

Yanan Gao

Yuting Hu

Ke Xu

Affiliations

Soon will be listed here.

Abstract

Background: Malignant neoplasms are a well-recognized global public health concern, with significant impacts on human health and quality of life. The interplay between tumors and autoimmune rheumatic diseases is complex, and the resulting tumor-associated rheumatic diseases represent a rare and intricate group of conditions that occur in the context of malignant tumors. In addition, various rheumatic diseases can arise as a consequence of oncology treatment. These diseases present with intricate clinical manifestations and pathological features, often rendering them challenging to diagnose and impacting patients' quality of life. Despite this, they have yet to be fully recognized.

Methods: This article presents a literature review of published original articles and review articles concerning paraneoplastic rheumatic syndromes and rheumatic diseases associated with cancer treatment. We conducted a comprehensive literature search in PubMed, Web of Science and Google Scholar databases, excluding duplicated and irrelevant studies. In cases of duplicated research, we selected articles with higher impact factors for the review.

Results: This review focuses on the clinical features, diagnosis, and treatment of paraneoplastic rheumatic diseases, as well as the pathogenesis of these diseases. Additionally, we summarize the autoimmune rheumatic diseases associated with cancer treatment. Ultimately, the goal of this review is to enhance recognition and improve the management of autoimmune rheumatic diseases related to tumors.

Citing Articles

Large-scale genome-wide association studies reveal the genetic causal etiology between ankylosing spondylitis and risk of leukemia and lymphocytic malignancies.

Li G, Dong C, Song Y, Gao F Front Oncol. 2024; 14:1432664.

PMID: 39319060 PMC: 11419960. DOI: 10.3389/fonc.2024.1432664.

Nephrotic syndrome associated with solid malignancies: a systematic review.

Liu S, Wan Y, Hu Z, Wang Z, Liu F BMC Nephrol. 2024; 25(1):215.

PMID: 38965515 PMC: 11225115. DOI: 10.1186/s12882-024-03632-9.

References

Hertz D, Douglas J, Miller R, Kidwell K, Gersch C, Desta Z . Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms. Support Care Cancer. 2022; 30(10):8059-8067. PMC: 9529953. DOI: 10.1007/s00520-022-07243-8. View

Mohokum M, Hartmann P, Schlattmann P . The association of Raynaud's syndrome with cisplatin-based chemotherapy - a meta-analysis. Eur J Intern Med. 2012; 23(7):594-8. DOI: 10.1016/j.ejim.2012.03.016. View

Berndt T, Schiavi S, Kumar R . "Phosphatonins" and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol. 2005; 289(6):F1170-82. DOI: 10.1152/ajprenal.00072.2005. View

Zhang Z, Xia W, He J, Zhang Z, Ke Y, Yue H . Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am J Hum Genet. 2011; 90(1):125-32. PMC: 3257902. DOI: 10.1016/j.ajhg.2011.11.019. View

van Marcke C, Seront E, Docquier C, Filleul B . Palmar fasciitis and polyarthritis, a rare paraneoplastic syndrome related to ovarian cancer. Clin Exp Dermatol. 2017; 42(3):328-330. DOI: 10.1111/ced.13071. View

Qureshi A, Saavedra A . Palmar fasciitis and polyarthritis syndrome in patients with ovarian cancer-a case report and review of the literature. Hand (N Y). 2012; 6(2):220-3. PMC: 3092898. DOI: 10.1007/s11552-010-9310-8. View

Shah M, Tayar J, Abdel-Wahab N, Suarez-Almazor M . Myositis as an adverse event of immune checkpoint blockade for cancer therapy. Semin Arthritis Rheum. 2018; 48(4):736-740. DOI: 10.1016/j.semarthrit.2018.05.006. View

Yang Z, Lin F, Qin B, Liang Y, Zhong R . Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol. 2014; 42(2):282-91. DOI: 10.3899/jrheum.140566. View

Dong J, Bian D, Feng Q . Gastrointestinal Multiple Adenomas in Primary Hypertrophic Osteoarthropathy. Mayo Clin Proc. 2022; 97(5):941-942. DOI: 10.1016/j.mayocp.2022.02.030. View

10.

Spain L, Diem S, Larkin J . Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev. 2016; 44:51-60. DOI: 10.1016/j.ctrv.2016.02.001. View

11.

Tupalli A, Angamuthu M, Prashanth A, Singh R, Kumar R . Intraosseous Medullary Fat Necrosis on 99mTc-MDP Bone Scan of Patient With Acute Pancreatitis. Clin Nucl Med. 2020; 45(6):e294-e295. DOI: 10.1097/RLU.0000000000003022. View

12.

Ichimura Y, Matsushita T, Hamaguchi Y, Kaji K, Hasegawa M, Tanino Y . Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis. 2012; 71(5):710-3. DOI: 10.1136/annrheumdis-2011-200697. View

13.

Matteson E, Dejaco C . Polymyalgia Rheumatica. Ann Intern Med. 2017; 166(9):ITC65-ITC80. DOI: 10.7326/AITC201705020. View

14.

Werquin S, Kacet S, Caron J, Lacroix D, Libersa C, Coget J . [Raynaud's phenomenon and finger necrosis after treatment of ovarian seminoma with bleomycin, vinblastine and 5-fluorouracil]. Ann Cardiol Angeiol (Paris). 1987; 36(8):409-12. View

15.

Johnson D, Nebhan C, Moslehi J, Balko J . Immune-checkpoint inhibitors: long-term implications of toxicity. Nat Rev Clin Oncol. 2022; 19(4):254-267. PMC: 8790946. DOI: 10.1038/s41571-022-00600-w. View

16.

Wagstaff A, Ibbotson T, Goa K . Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer. Drugs. 2003; 63(2):217-36. DOI: 10.2165/00003495-200363020-00009. View

17.

Yamashita H, Ueda Y, Ozaki T, Tsuchiya H, Takahashi Y, Kaneko H . Characteristics of 10 patients with paraneoplastic rheumatologic musculoskeletal manifestations. Mod Rheumatol. 2013; 24(3):492-8. DOI: 10.3109/14397595.2013.843762. View

18.

Narvaez J, Bianchi M, Santo P, Fuente D, Rios-Rodriguez V, Bolao F . Pancreatitis, panniculitis, and polyarthritis. Semin Arthritis Rheum. 2008; 39(5):417-23. DOI: 10.1016/j.semarthrit.2008.10.001. View

19.

Uppal S, Diggle C, Carr I, Fishwick C, Ahmed M, Ibrahim G . Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet. 2008; 40(6):789-93. DOI: 10.1038/ng.153. View

20.

Azar L, Khasnis A . Paraneoplastic rheumatologic syndromes. Curr Opin Rheumatol. 2012; 25(1):44-9. DOI: 10.1097/BOR.0b013e328359e780. View